Other cell types, C3(NK) C7(NKT), and C12 (Gamma delta T) are notably reduced in tumors; on the contrary, the proportion of C14: CD3-STMN1 (proliferating cells), C17: CD3-IFI6 (type I interferon signaling pathway activated T cells) increased significantly in the tumor. This evidence concerns the gene STMN1 and neoplasm.